Search Results

There are 15451 results for: content related to: Three times weekly glatiramer acetate in relapsing–remitting multiple sclerosis

  1. Phase III dose-comparison study of glatiramer acetate for multiple sclerosis

    Annals of Neurology

    Volume 69, Issue 1, January 2011, Pages: 75–82, Giancarlo Comi, Jeffrey A. Cohen, Douglas L. Arnold, Daniel Wynn, Massimo Filippi and for the FORTE Study Group

    Version of Record online : 28 JAN 2011, DOI: 10.1002/ana.22316

  2. You have free access to this content
    Glatiramer acetate inhibition of tumor necrosis factor-α-induced RANTES expression and release from U-251 MG human astrocytic cells

    Journal of Neurochemistry

    Volume 77, Issue 5, June 2001, Pages: 1208–1217, Qingdi Q. Li, ,, David R. Burt and Christopher T. Bever,,

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1471-4159.2001.00327.x

  3. Randomized study combining interferon and glatiramer acetate in multiple sclerosis

    Annals of Neurology

    Volume 73, Issue 3, March 2013, Pages: 327–340, Fred D. Lublin, Stacey S. Cofield, Gary R. Cutter, Robin Conwit, Ponnada A. Narayana, Flavia Nelson, Amber R. Salter, Tarah Gustafson, Jerry S. Wolinsky and for the CombiRx Investigators

    Version of Record online : 11 MAR 2013, DOI: 10.1002/ana.23863

  4. You have free access to this content
    Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Graziella Filippini, Cinzia Del Giovane, Laura Vacchi, Roberto D'Amico, Carlo Di Pietrantonj, Deirdre Beecher and Georgia Salanti

    Published Online : 6 JUN 2013, DOI: 10.1002/14651858.CD008933.pub2

  5. Glatiramer acetate for multiple sclerosis

    Intervention Review

    The Cochrane Library

    Loredana La Mantia, Luca M Munari and Roberta Lovati

    Published Online : 12 MAY 2010, DOI: 10.1002/14651858.CD004678.pub2

  6. Lobular panniculitis at the site of glatiramer acetate injections for the treatment of relapsing-remitting multiple sclerosis. A report of two cases

    Journal of Cutaneous Pathology

    Volume 35, Issue 4, April 2008, Pages: 407–410, Nigel J. Ball, Bryce J. Cowan, G. R. Wayne Moore and Stanley A. Hashimoto

    Version of Record online : 1 OCT 2007, DOI: 10.1111/j.1600-0560.2007.00819.x

  7. IgE-mediated hypersensitivity reaction and desensitization to glatiramer acetate in a pediatric patient

    Pediatric Allergy and Immunology

    Volume 25, Issue 8, December 2014, Pages: 821–823, E. Crestani, J. Lee, M. Gorman, M. Castells and A. F. Dioun Broyles

    Version of Record online : 16 OCT 2014, DOI: 10.1111/pai.12267

  8. Current Disease-Modifying Treatment of Multiple Sclerosis

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 78, Issue 2, March/April 2011, Pages: 161–175, Joy Derwenskus

    Version of Record online : 21 MAR 2011, DOI: 10.1002/msj.20239

  9. You have free access to this content
    Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Irene Tramacere, Cinzia Del Giovane, Georgia Salanti, Roberto D'Amico and Graziella Filippini

    Published Online : 18 SEP 2015, DOI: 10.1002/14651858.CD011381.pub2

  10. Clinical and magnetic resonance imaging findings in chronic sensory ganglionopathies

    Annals of Neurology

    Volume 47, Issue 1, January 2000, Pages: 104–109, Giuseppe Lauria, Davide Pareyson, Marina Grisoli and Angelo Sghirlanzoni

    Version of Record online : 19 APR 2001, DOI: 10.1002/1531-8249(200001)47:1<104::AID-ANA17>3.0.CO;2-X

  11. Immunomodulation by the copolymer glatiramer acetate

    Journal of Molecular Recognition

    Volume 16, Issue 6, November/December 2003, Pages: 412–421, Ruth Arnon and Michael Sela

    Version of Record online : 21 NOV 2003, DOI: 10.1002/jmr.628

  12. Intraoperative unmasking of brain redundant motor sites during resection of a precentral angioma: Evidence using direct cortical stimulation

    Annals of Neurology

    Volume 47, Issue 1, January 2000, Pages: 132–135, Hugues Duffau, Jean-Pierre Sichez and Stéphane Lehéricy

    Version of Record online : 19 APR 2001, DOI: 10.1002/1531-8249(200001)47:1<132::AID-ANA23>3.0.CO;2-0

  13. Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-α) does not improve experimental autoimmune encephalomyelitis

    Annals of Neurology

    Volume 47, Issue 1, January 2000, Pages: 127–131, Staley A. Brod, J. William Lindsey and Jerry S. Wolinsky

    Version of Record online : 19 APR 2001, DOI: 10.1002/1531-8249(200001)47:1<127::AID-ANA22>3.0.CO;2-1

  14. A longitudinal observational study of a cohort of patients with relapsing–remitting multiple sclerosis treated with glatiramer acetate

    European Journal of Neurology

    Volume 14, Issue 11, November 2007, Pages: 1266–1274, M. Debouverie, T. Moreau, C. Lebrun, O. Heinzlef, F. Brudon and J. Msihid

    Version of Record online : 19 OCT 2007, DOI: 10.1111/j.1468-1331.2007.01964.x

  15. Diffusion-weighted magnetic resonance imaging in boys with neural cell adhesion molecule L1 mutations and congenital hydrocephalus

    Annals of Neurology

    Volume 47, Issue 1, January 2000, Pages: 113–117, William D. Graf, Donald E. Born, Dennis W. W. Shaw, John R. Thomas, Lynda W. Holloway and Ron C. Michaelis

    Version of Record online : 19 APR 2001, DOI: 10.1002/1531-8249(200001)47:1<113::AID-ANA19>3.0.CO;2-P

  16. Endothelin-1 in the brain of patients with galactosialidosis: Its abnormal increase and distribution pattern

    Annals of Neurology

    Volume 47, Issue 1, January 2000, Pages: 122–126, Kohji Itoh, Kiyomitsu Oyanagi, Hitoshi Takahashi, Takeshi Sato, Yoshio Hashizume, Michie Shimmoto and Hitoshi Sakuraba

    Version of Record online : 19 APR 2001, DOI: 10.1002/1531-8249(200001)47:1<122::AID-ANA21>3.0.CO;2-9

  17. Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate

    Acta Neurologica Scandinavica

    Volume 104, Issue 5, November 2001, Pages: 266–270, O. Aktas, N. Ari, M. Rieks, V. Hoffmann, S. Schimrigk, H. Przuntek and D. Pöhlau

    Version of Record online : 7 JUL 2008, DOI: 10.1034/j.1600-0404.2001.00125.x

  18. You have free access to this content
    New and emerging immune-targeted drugs for the treatment of multiple sclerosis

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 33–43, Alan M. Palmer

    Version of Record online : 20 JUN 2014, DOI: 10.1111/bcp.12285

  19. Hemizygous mutation of the peripheral myelin protein 22 gene associated with Charcot-Marie-Tooth disease type 1

    Annals of Neurology

    Volume 47, Issue 1, January 2000, Pages: 101–103, Chikahiko Numakura, Changqing Lin, Nobuyuki Oka, Ichiro Akiguchi and Kiyoshi Hayasaka

    Version of Record online : 19 APR 2001, DOI: 10.1002/1531-8249(200001)47:1<101::AID-ANA16>3.0.CO;2-2